Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Clinically significant drug interactions in dermatology

V P Barranco1

  • 1Department of Dermatology, University of Oklahoma Health Sciences Center, Tulsa, USA.

Journal of the American Academy of Dermatology
|April 29, 1998
PubMed
Summary

Finding clinically significant drug interactions is difficult, causing uncertainty for healthcare providers. This study discusses drug interaction pharmacology, highlighting common hepatic metabolism alterations and identifying "red flag" drugs for dermatologists.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drug delay and the FDA.

International journal of dermatology·1992
Same author

Mustard gas and the dermatologist.

International journal of dermatology·1991
Same author

Multiple benign lichenoid keratoses simulating photodermatoses: evolution from senile lentigines and their spontaneous regression.

Journal of the American Academy of Dermatology·1985
Same author

Dapsone--other indications.

International journal of dermatology·1982
Same author

Letter: Topically applied lincomycin for acne.

Archives of dermatology·1976
Same author

Treatment of relapsing polychondritis with dapsone.

Archives of dermatology·1976

Area of Science:

  • Pharmacology
  • Drug Interactions
  • Dermatology

Background:

  • Clinically significant drug interaction information is not readily accessible, leading to uncertainty and time-consuming searches.
  • Drug interactions often involve altered hepatic metabolism, a key area of pharmacological study.
  • Identifying high-risk medications is crucial for patient safety.

Purpose of the Study:

  • To address the lack of accessible information on clinically significant drug interactions.
  • To discuss the pharmacology of common drug interactions, particularly those affecting hepatic metabolism.
  • To provide dermatologists with a comprehensive list of significant drug interactions relevant to their practice.

Main Methods:

  • Review of pharmacological literature on drug interactions.

Related Experiment Videos

  • Identification of drugs frequently involved in significant interactions.
  • Compilation of a categorized list of drug interactions pertinent to dermatology.

    • Main Results:

    • Common drug interactions frequently involve altered hepatic metabolism.
    • At least 26 drugs are identified as "red flag" medications due to frequent interactions.
    • An extensive list of significant and less significant drug interactions for dermatologists is presented.

    Conclusions:

    • Improved accessibility to drug interaction data is needed.
    • Understanding hepatic metabolism is key to managing drug interactions.
    • The provided list serves as a valuable resource for dermatologists to mitigate risks associated with drug interactions.